Effects of extracorporeal shock wave therapy on spasticity in patients after brain injury: A meta-analysis

Journal of Physical Therapy Science

Volumn 26, Issue 10, 2014, Pages 1641-1647

  Lee, Jin Youn ^a   Kim, Soo Nyung ^a   Lee, In Sik ^a   Jung, Heeyoune ^a   Lee, Kyeong Soo ^a   Koh, Seong Eun ^a  

^a Konkuk University Hospital   (South Korea)

Author keywords

Extracorporeal shock wave therapy; Meta analysis; Spasticity

Indexed keywords

EID: 84908228563     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.26.1641     Document Type: Review

References (62)

1. Sheean G, McGuire JR: Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PM R, 2009, 1: 827–833. [Medline] [CrossRef]
2. Hufschmidt A, Mauritz KH: Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry, 1985, 48: 676–685. [Medline] [CrossRef]
3. Galiana L, Fung J, Kearney R: Identification of intrinsic and reflex ankle stiffness components in stroke patients. Exp Brain Res, 2005, 165: 422–434. [Medline] [CrossRef]
4. Sinkjaer T, Toft E, Larsen K, et al.: Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve, 1993, 16: 69–76. [Medline] [CrossRef]
5. Dietz V, Sinkjaer T: Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol, 2007, 6: 725–733. [Medline] [CrossRef]
6. Frontera WR: Spasticity and muscle overactivity as components of the upper motor neuron syndrome. In: DeLisa’s Physical Medicine & Rehabilitation: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2010, pp 1323–1337.
7. Chaussy C, Brendel W, Schmiedt E: Extracorporeally induced destruction of kidney stones by shock waves. Lancet, 1980, 2: 1265–1268. [Medline] [CrossRef]
8. Valchanou VD, Michailov P: High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop, 1991, 15: 181–184. [Medline] [CrossRef]
9. Rompe JD, Decking J, Schoellner C, et al.: Shock wave application for chronic plantar fasciitis in running athletes. A prospective, randomized, placebo-controlled trial. Am J Sports Med, 2003, 31: 268–275. [Medline]
10. Ronald VB, Dale M, James WF: An evaluation of research evidence for selected physical therapy interventions for plantar fasciitis. J Phys Ther Sci, 2007, 19: 41–56. [CrossRef]
11. Rompe JD, Zoellner J, Nafe B: Shock wave therapy versus conventional surgery in the treatment of calcifying tendinitis of the shoulder. Clin Orthop Relat Res, 2001, (387): 72–82. [Medline] [CrossRef]
12. Loew M, Daecke W, Kusnierczak D, et al.: Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder. J Bone Joint Surg Br, 1999, 81: 863–867. [Medline] [CrossRef]
13. Wang CJ: An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J, 2003, 26: 220–232. [Medline]
14. Lee JH, Han EY: A comparison of the effects of PNF, ESWT, and TPI on pain and function of patients with myofascial pain syndrome. J Phys Ther Sci, 2013, 25: 341–344. [CrossRef]
15. Cho YS, Park SJ, Jang SH, et al.: Effects of the combined treatment of extracorporeal shock wave therapy (ESWT) and stabilization exercises on pain and functions of patients with myofascial pain syndrome. J Phys Ther Sci, 2012, 24: 1319–1323. [CrossRef]
16. Wang CJ, Huang HY, Pai CH: Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg, 2002, 41: 16–22. [Medline] [CrossRef]
17. Ciampa AR, de Prati AC, Amelio E, et al.: Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett, 2005, 579: 6839–6845. [Medline] [CrossRef]
18. Zhang X, Yan X, Wang C, et al.: The dose-effect relationship in extracorporeal shock wave therapy: the optimal parameter for extracorporeal shock wave therapy. J Surg Res, 2014, 186: 484–492. [Medline] [CrossRef]
19. Mariotto S, Cavalieri E, Amelio E, et al.: Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide, 2005, 12: 89–96. [Medline] [CrossRef]
20. Cochrane Collaboration: Cochrane handbook for systematic reviews of interventions. Ver. 5.1.0. http://handbook.cochrane.org (Accessed Mar. 2011)
21. Hatala R, Keitz S, Wyer P, et al. Evidence-Based Medicine Teaching Tips Working Group: Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ, 2005, 172: 661–665. [Medline] [CrossRef]
22. Der Simonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7: 177–188. [Medline] [CrossRef]
23. Egger M, Smith GD, Phillips AN: Meta-analysis: principles and procedures. BMJ, 1997, 315: 1533–1537. [Medline] [CrossRef]
24. Lance J: Spasticity: disordered motor control. In: Symposium synopsis. Miami: Year Book Medical Publishers, 1980, pp 485–494.
25. Berger W, Horstmann G, Dietz V: Tension development and muscle activation in the leg during gait in spastic hemiparesis: independence of muscle hypertonia and exaggerated stretch reflexes. J Neurol Neurosurg Psychiatry, 1984, 47: 1029–1033. [Medline] [CrossRef]
26. Thompson AJ, Jarrett L, Lockley L, et al.: Clinical management of spasticity. J Neurol Neurosurg Psychiatry, 2005, 76: 459–463. [Medline] [Cross- Ref]
27. Gonkova MI, Ilieva EM, Ferriero G, et al.: Effect of radial shock wave therapy on muscle spasticity in children with cerebral palsy. Int J Rehabil Res, 2013, 36: 284–290. [Medline] [CrossRef]
28. Amelio E, Manganotti P: Effect of shock wave stimulation on hypertonic plantar flexor muscles in patients with cerebral palsy: a placebo-controlled study. J Rehabil Med, 2010, 42: 339–343. [Medline] [CrossRef]
29. Moon SW, Kim JH, Jung MJ, et al.: The effect of extracorporeal shock wave therapy on lower limb spasticity in subacute stroke patients. Ann Rehabil Med, 2013, 37: 461–470. [Medline] [CrossRef]
30. Sohn MK, Cho KH, Kim YJ, et al.: Spasticity and electrophysiologic changes after extracorporeal shock wave therapy on gastrocnemius. Ann Rehabil Med, 2011, 35: 599–604. [Medline] [CrossRef]
31. Manganotti P, Amelio E: Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke, 2005, 36: 1967–1971. [Medline] [CrossRef]
32. Thibaut A, Chatelle C, Ziegler E, et al.: Spasticity after stroke: physiology, assessment and treatment. Brain Inj, 2013, 27: 1093–1105. [Medline] [CrossRef]
33. Spira R: Management of spasticity in cerebral palsied children by peripheral nerve block with phenol. Dev Med Child Neurol, 1971, 13: 164–173. [Medline] [CrossRef]
34. Yadav SL, Singh U, Dureja GP, et al.: Phenol block in the management of spastic cerebral palsy. Indian J Pediatr, 1994, 61: 249–255. [Medline] [CrossRef]
35. Tardieu G, Tardieu C, Hariga J, et al.: Treatment of spasticity in injection of dilute alcohol at the motor point or by epidural route. Clinical extension of an experiment on the decerebrate cat. Dev Med Child Neurol, 1968, 10: 555–568. [Medline] [CrossRef]
36. Burbaud P, Wiart L, Dubos JL, et al.: A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry, 1996, 61: 265–269. [Medline] [CrossRef]
37. Corry IS, Cosgrove AP, Walsh EG, et al.: Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol, 1997, 39: 185–193. [Medline] [CrossRef]
38. El O, Peker O, Kosay C, et al.: Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy. J Child Neurol, 2006, 21: 1009–1012. [Medline] [CrossRef]
39. Fehlings D, Rang M, Glazier J, et al.: An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr, 2000, 137: 331–337. [Medline] [CrossRef]
40. Koman LA, Mooney JF 3rd, Smith BP, et al.: Management of spasticity in cerebral palsy with botulinum—A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop, 1994, 14: 299–303. [Medline] [CrossRef]
41. Lagalla G, Danni M, Reiter F, et al.: Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil, 2000, 79: 377–384, quiz 391–394. [Medline] [CrossRef]
42. Buckon CE, Thomas SS, Piatt JH Jr, et al.: Selective dorsal rhizotomy versus orthopedic surgery: a multidimensional assessment of outcome efficacy. Arch Phys Med Rehabil, 2004, 85: 457–465. [Medline] [CrossRef]
43. Wright FV, Sheil EM, Drake JM, et al.: Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol, 1998, 40: 239–247. [Medline] [Cross- Ref]
44. McLaughlin JF, Bjornson KF, Astley SJ, et al.: Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol, 1998, 40: 220–232. [Medline] [CrossRef]
45. Penn RD, Savoy SM, Corcos D, et al.: Intrathecal baclofen for severe spinal spasticity. N Engl J Med, 1989, 320: 1517–1521. [Medline] [CrossRef]
46. Albright AL, Cervi A, Singletary J: Intrathecal baclofen for spasticity in cerebral palsy. JAMA, 1991, 265: 1418–1422. [Medline] [CrossRef]
47. Gilmartin R, Bruce D, Storrs BB, et al.: Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol, 2000, 15: 71–77. [Medline] [CrossRef]
48. Van Schaeybroeck P, Nuttin B, Lagae L, et al.: Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, doubleblind study. Neurosurgery, 2000, 46: 603–609, discussion 609–612. [Medline] [CrossRef]
49. Jankovic J, Schwartz KS: Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology, 1993, 43: 834–836. [Medline] [CrossRef]
50. Siatkowski RM, Tyutyunikov A, Biglan AW, et al.: Serum antibody production to botulinum A toxin. Ophthalmology, 1993, 100: 1861–1866. [Medline] [CrossRef]
51. Shrivastava SK, Kailash: Shock wave treatment in medicine. J Biosci, 2005, 30: 269–275. [Medline] [CrossRef]
52. Molina JA, Jiménez-Jiménez FJ, Ortí-Pareja M, et al.: The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging, 1998, 12: 251–259. [Medline] [CrossRef]
53. Gotte G, Amelio E, Russo S, et al.: Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett, 2002, 520: 153–155. [Medline] [CrossRef]
54. Lieber RL, Steinman S, Barash IA, et al.: Structural and functional changes in spastic skeletal muscle. Muscle Nerve, 2004, 29: 615–627. [Medline] [CrossRef]
55. Chang KV, Chen SY, Chen WS, et al.: Comparative effectiveness of focused shock wave therapy of different intensity levels and radial shock wave therapy for treating plantar fasciitis: a systematic review and network meta-analysis. Arch Phys Med Rehabil, 2012, 93: 1259–1268. [Medline] [CrossRef]
56. Foldager CB, Kearney C, Spector M: Clinical application of extracorporeal shock wave therapy in orthopedics: focused versus unfocused shock waves. Ultrasound Med Biol, 2012, 38: 1673–1680. [Medline] [CrossRef]
57. Mittermayr R, Antonic V, Hartinger J, et al.: Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen, 2012, 20: 456–465. [Medline]
58. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner, 1964, 192: 540–542. [Medline]
59. Morris S: Ashworth and Tardieu Scales: their clinical relevance for measureing spasticity in adult and paediatric neurological populations. Phys Ther Rev, 2002, 7: 53–62. [CrossRef]
60. Pandyan AD, Johnson GR, Price CI, et al.: A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil, 1999, 13: 373–383. [Medline] [CrossRef]
61. Mehrholz J, Major Y, Meissner D, et al.: The influence of contractures and variation in measurement stretching velocity on the reliability of the Modified Ashworth Scale in patients with severe brain injury. Clin Rehabil, 2005, 19: 63–72. [Medline] [CrossRef]
62. Mehrholz J, Wagner K, Meissner D, et al.: Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clin Rehabil, 2005, 19: 751–759. [Medline] [CrossRef]